Abstract
Included in a large group of autoimmune diseases, Multiple Sclerosis (MS) affected about 2.8 million people globally by the year 2020, according to data from the National Multiple Sclerosis Society (2020). MS is a potentially disabling pathology because it greatly affects the Central Nervous System (CNS), and thus promotes the observed clinical symptoms. This is because the immune system …